UDP-Gal.2Na
Price | Get Latest Price |
Package | 50mg |
Min. Order: | 10mg |
Supply Ability: | MG-KG |
Update Time: | 2020-03-26 |
Product Details
Product Name: UDP-Gal.2Na | CAS No.: 137868-52-1 |
Min. Order: 10mg | Purity: 97%HPLC |
Supply Ability: MG-KG | Release date: 2020/03/26 |
Glycopharm.LLC was founded in Wuhan, China in April 2019. Our company has an outstanding research team engaged in the synthesis of carbohydrates, such as sugar based drug, common sugar intermedia, sugar nucleotides and so on. Our company’s mission was to accelerate your research on glycoscience from all scientific research communities. We can provide qualified products from milligram to kilograms according to client’s requirement.
Company Profile Introduction
Glycopharm.LLC was founded in Wuhan, China in April 2019. Our company has an outstanding research team engaged in the synthesis of sugar-based drug, e.g. glycolipids, glycopeptides, vaccines and so on. Our company’s mission was to provide solutions to the synthesis of all valuable sugar-based molecules in glycoscience. Our scientists are well educated to prepare sugar-based molecules in chemical and enzymatic way.
Our company was equipped with very strict analytic instruments, e.g. HPLC, MS, NMR, to guarantee the high quality of each delivered product. We are trying our best to provide the highest quality of services and products and at the same time maintain very attractive prices to make sure that we are beneficial to your business development.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1g |
VIP3Y
|
BioChemSyn LLC
|
2022-06-10 | |
$0.00/1kg |
VIP3Y
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2024-11-21 | |
$31.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-20 | |
$1.00/1kg |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-04 |
- Since: 2019-04-23
- Address: Room 228, Building C6, Biological Innovation Park, No. 666 Gaoxin Avenue, Donghu New Technology Deve
INQUIRY